相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Encorafenib Plus Cetuximab as a New Standard of Care for Previously Treated BRAF V600E-Mutant Metastatic Colorectal Cancer: Updated Survival Results and Subgroup Analyses from the BEACON Study
Josep Tabernero et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Discovery of a Covalent Inhibitor of KRASG12C (AMG 510) for the Treatment of Solid Tumors
Brian A. Lanman et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
ERK signalling: a master regulator of cell behaviour, life and fate
Hugo Lavoie et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2020)
MAPK Pathway Suppression Unmasks Latent DNA Repair Defects and Confers a Chemical Synthetic Vulnerability in BRAF-, NRAS-, and NF1-Mutant Melanomas
Ophelia Maertens et al.
CANCER DISCOVERY (2019)
HDAC Inhibition Enhances the In Vivo Efficacy of MEK Inhibitor Therapy in Uveal Melanoma
Fernanda Faiao-Flores et al.
CLINICAL CANCER RESEARCH (2019)
The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity
Jude Canon et al.
NATURE (2019)
Targeting melanoma's MCL1 bias unleashes the apoptotic potential of BRAF and ERK1/2 pathway inhibitors
Matthew J. Sale et al.
NATURE COMMUNICATIONS (2019)
An Acquired Vulnerability of Drug-Resistant Melanoma with Therapeutic Potential
Liqin Wang et al.
CELL (2018)
Exploiting MCL1 Dependency with Combination MEK+MCL1 Inhibitors Leads to Induction of Apoptosis and Tumor Regression in KRAS-Mutant Non-Small Cell Lung Cancer
Varuna Nangia et al.
CANCER DISCOVERY (2018)
MEK inhibitors induce apoptosis via FoxO3a-dependent PUMA induction in colorectal cancer cells
Lin Lin et al.
ONCOGENESIS (2018)
ATF3 Repression of BCL-XL Determines Apoptotic Sensitivity toHDACInhibitors across Tumor Types
Anderly C. Chueh et al.
CLINICAL CANCER RESEARCH (2017)
Histone Deacetylase Inhibitor Enhances the Efficacy of MEK Inhibitor through NOXA-Mediated MCL1 Degradation in Triple-Negative and Inflammatory Breast Cancer
Angie M. Torres-Adorno et al.
CLINICAL CANCER RESEARCH (2017)
Mutant BRAF Upregulates MCL-1 to Confer Apoptosis Resistance that Is Reversed by MCL-1 Antagonism and Cobimetinib in Colorectal Cancer
Hisato Kawakami et al.
MOLECULAR CANCER THERAPEUTICS (2016)
Mechanisms of Histone Deacetylase Inhibitor-Regulated Gene Expression in Cancer Cells
Anderly C. Chueh et al.
ANTIOXIDANTS & REDOX SIGNALING (2015)
An Inducible Lentiviral Guide RNA Platform Enables the Identification of Tumor-Essential Genes and Tumor-Promoting Mutations In Vivo
Brandon J. Aubrey et al.
CELL REPORTS (2015)
MEK1 and MEK2 inhibitors and cancer therapy: the long and winding road
Christopher J. Caunt et al.
NATURE REVIEWS CANCER (2015)
New and emerging HDAC inhibitors for cancer treatment
Alison C. West et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
HDAC8 and STAT3 repress BMF gene activity in colon cancer cells
Y. Kang et al.
CELL DEATH & DISEASE (2014)
HDAC inhibitors induce tumor-cell-selective pro-apoptotic transcriptional responses
J. E. Bolden et al.
CELL DEATH & DISEASE (2013)
Comprehensive molecular characterization of human colon and rectal cancer
Donna M. Muzny et al.
NATURE (2012)
ERK2 phosphorylation of serine 77 regulates Bmf pro-apoptotic activity
Y. Shao et al.
CELL DEATH & DISEASE (2012)
Deciphering the Molecular Events Necessary for Synergistic Tumor Cell Apoptosis Mediated by the Histone Deacetylase Inhibitor Vorinostat and the BH3 Mimetic ABT-737
Adrian P. Wiegmans et al.
CANCER RESEARCH (2011)
PIK3CA mutation/PTEN expression status predicts response of colon cancer cells to the epidermal growth factor receptor inhibitor cetuximab
Minaxi Jhawer et al.
CANCER RESEARCH (2008)
Discovery of N-(2-aminophenyl)4-[4-pyridin-3-ylpyrimidin-2-ylamino)methyl]benzamide (MGCD0103), an orally active histone deacetylase inhibitor
Nancy Zhou et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Multisite phosphorylation regulates Bim stability and apoptotic activity
Anette Hubner et al.
MOLECULAR CELL (2008)
ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation
Jer-Yen Yang et al.
NATURE CELL BIOLOGY (2008)
Cetuximab for the treatment of colorectal cancer
Derek J. Jonker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Mouse model of colonic adenoma-carcinoma progression based on somatic Apc inactivation
Takao Hinoi et al.
CANCER RESEARCH (2007)
Gefitinib-induced killing of NSCLC cell lines expressing mutant EGFR requires BIM and can be enhanced by BH3 mimetics
Mark S. Cragg et al.
PLOS MEDICINE (2007)
ERK1/2-dependent phosphorylation of BimEL promotes its rapid dissociation from Mcl-1 and Bcl-xL
Katherine E. Ewings et al.
EMBO JOURNAL (2007)
Bmf is a possible mediator in histone deacetylase inhibitors FK228 and CBHA-induced apoptosis
Y Zhang et al.
CELL DEATH AND DIFFERENTIATION (2006)
Inhibitors of histone deacetylases target the Rb-E2F1 pathway for apoptosis induction through activation of proapoptotic protein Bim
Y Zhao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Coadministration of histone deacetylase inhibitors and perifosine synergistically induces apoptosis in human leukemia cells through Akt and ERK1/2 inactivation and the generation of ceramide and reactive oxygen species
M Rahmani et al.
CANCER RESEARCH (2005)
Histone deacetylase inhibitors down-regulate bcl-2 expression and induce apoptosis in t(14;18) lymphomas
H Duan et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function
L Chen et al.
MOLECULAR CELL (2005)
Role of Bim in the survival pathway induced by Raf in epithelial cells
M Marani et al.
ONCOGENE (2004)
MCL1 is phosphorylated in the PEST region and stabilized upon ERK activation in viable cells, and at additional sites with cytotoxic okadaic acid or taxol
AM Domina et al.
ONCOGENE (2004)
Genome signatures of colon carcinoma cell lines
K Kleivi et al.
CANCER GENETICS AND CYTOGENETICS (2004)
Activation of the ERK1/2 signaling pathway promotes phosphorylation and proteasome-dependent degradation of the BH3-only protein, Bim
R Ley et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Evaluation of the epidermal growth factor receptor (EGFR) in colorectal tumours and lymph node metastases
JA McKay et al.
EUROPEAN JOURNAL OF CANCER (2002)
Identification of two Sp1 phosphorylation sites for p42/p44 mitogen-activated protein kinases -: Their implication in vascular endothelial growth factor gene transcription
J Milanini-Mongiat et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
分享论文
